Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).

Authors :: Hanna CR
O'Cathail SM
Graham JS
Saunders M
Samuel L
Harrison M
Devlin L
Edwards J
Gaya DR
Kelly CA
Lewsley LA
Maka N
Morrison P
Dinnett L
Dillon S
Gourlay J
Platt JJ
Thomson F
Adams RA
Roxburgh CSD
Source :: Radiation oncology (London, England) [Radiat Oncol] 2021 Dec 02; Vol. 16 (1), pp. 230. Date of Electronic Publication: 2021 Dec 02.
Publication Year :: 2021

Full Text Access

Tools